Computational methods of studying the binding of toxins from venomous animals to biological ion channels: Theory and applications

Physiological Reviews

Volumn 93, Issue 2, 2013, Pages 767-802

  Gordon, Dan ^a   Chen, Rong ^a   Chung, Shin Ho ^a  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ION CHANNEL; POTASSIUM CHANNEL; SODIUM CHANNEL;

ARTICLE; CHEMICAL STRUCTURE; COMPUTER ANALYSIS; DISSOCIATION CONSTANT; ENERGY TRANSFER; FORCE; GEOMETRY; HEART ATRIUM FIBRILLATION; LONG QT SYNDROME; MOLECULAR DOCKING; MOLECULAR DYNAMICS; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; STATISTICAL ANALYSIS; STRUCTURE ACTIVITY RELATION; THEORETICAL STUDY;

ANIMALS; COMPUTER SIMULATION; HUMANS; ION CHANNELS; MODELS, MOLECULAR; TOXINS, BIOLOGICAL; VENOMS;

EID: 84873371685     PISSN: 00319333     EISSN: 15221210     Source Type: Journal    
DOI: 10.1152/physrev.00035.2012     Document Type: Article

References (266)

1. Abdel-Halim H, Hanrahan JR, Hibbs DE, Johnston GAR, Chebib M. A molecular basis for agonist and antagonist actions at GABA(C) receptors. Chem Biol Drug Des 71: 306-327, 2008.
2. Abriel H. Roles and regulation of the cardiac sodium channel Nav1.5: recent insights from experimental studies. Cardiovasc Res 76: 381-389, 2007.
3. + channel revealed by the NMR-derived structures of scorpion toxins. Neuron 15: 1169-1181, 1995.
4. Ajeet. In silico designing and characterization of amiloride derivatives as ion channel modulator. Med Chem Res 1-7, 2012.
5. Alabi AA, Bahamonde MI, Jung HJ, Kim JI, Swartz KJ. Portability of paddle motif function and pharmacology in voltage sensors. Nature 450: 370-376, 2007.
6. Andér M, Luzhkov VB, Aqvist J. Ligand binding to the voltage-gated Kv1.5 potassium channel in the open state-docking and computer simulations of a homology model. Biophys J 94: 820-831, 2008.
7. Andreotti N, di Luccio E, Sampieri F, De Waard M, Sabatier JM. Molecular modeling and docking simulations of scorpion toxins and related analogs on human SKCa2 and SKCa3 channels. Peptides 26: 1095-1108, 2005.
8. Andrusier N, Mashiach E, Nussinov R, Wolfson HJ. Principles of flexible proteinprotein docking. Proteins 73: 271-289, 2008.
9. Aqvist J, Marelius J. The linear interaction energy method for predicting ligand binding free energies. Comb Chem High Throughput Screen 4: 613-626, 2001.
10. Aqvist J, Luzhkov VB, Brandsdal BO. Ligand binding affinities from MD simulations. Acc Chem Res 35: 358-365, 2002.
11. Aronov AM, Balakin KV, Kiselyov A, Varma-O'Brien S, Ekins S. Applications of QSAR methods to ion channels. In: Computational Toxicology, edited by Ekins, S. Hoboken, NJ: Wiley, 2006.
12. Ashcroft FM. Ion Channels and Disease. San Diego, CA: Academic, 2000.
13. Baştǔg T, Chen P, Patra S, Kuyucak S. Potential of mean force calculations of ligand binding to ion channels from Jarzynskis equality and umbrella sampling. J Chem Phys 128: 155104, 2008.
14. + channels but not in skeletal and cardiac muscles. J Biol Chem 279: 4680-4685, 2004.
15. Bashford D, Case DA. Generalized Born models of macromolecular solvation effects. Annu Rev Phys Chem 51: 129-152, 2000.
16. Beard DA, Schlick T. Unbiased rotational moves for rigid-body Brownian dynamics. Biophys J 85: 2973-2976, 2003.
17. Bemporad D, Sands ZA, Wee CL, Grottesi A, Sansom MSP. Vstx1, a modifier of Kv channel gating, localizes to the interfacial region of lipid bilayers. Biochemistry 45: 11844-11855, 2006.
18. Ben-Naim A. Statistical potentials extracted from protein structures: Are these meaningful potentials? J Chem Phys 107: 3698, 1997.
19. Berendsen HJC. Simulating the Physical World. Cambridge, UK: Cambridge Univ. Press, 2007.
20. Berezhnoy D, Gibbs TT, Farb DH. Docking of 1,4-benzodiazepines in the α1/γ2 GABAA receptor modulator site. Mol Pharmacol 76: 440-450, 2009.
21. + channel. Proc Natl Acad Sci USA 100: 8644-8648, 2003.
22. Blanc E, Sabatier JM, Kharrat R, Meunier S, el Ayeb M, van Rietschoten J, Darbon H. Solution structure of maurotoxin, a scorpion toxin from Scorpio maurus, with high affinity for voltage-gated potassium channels. Proteins 29: 321-333, 1997.
23. Bontems F, Gilquin BCR, Ménez A, Toma F. Analysis of side-chain organization on a refined model of charybdotoxin: structural and functional implications. Biochemistry 31: 7756-7764, 1992.
24. Bonvin AMJJ. Flexible protein-protein docking. Curr Opin Struct Biol 16: 194-200, 2006.
25. + ion channel. Science 335: 436-441, 2012.
26. Brooks BR, Brooks CL, III, Mackerell AD, Nilsson L, Petrella RJ, Roux B, Won Y, Archontis G, Bartels C, Boresch S, Caflisch A, Caves L, Cui Q, Dinner AR, Feig M, Fischer S, Gao J, Hodoscek M, Im W, Kuczera K, Lazaridis T, Ma J, Ovchinnikov V, Paci E, Pastor RW, Post CB, Pu JZ, Schaefer M, Tidor B, Venable RM, Woodcock HL, Wu X, Yang W, York DM, Karplus M. CHARMM: The biomolecular simulation program. J Comp Chem 30: 1545-1615, 2009.
27. Burykin A, Schutz CN, Villa J, Warshel A. Simulations of ion current in realistic models of ion channels: The KcsA potassium channel. Proteins: Struct Funct Genet 47: 265-280, 2002.
28. + channel. J Mol Model 13: 579-586, 2007.
29. Canul-Tec JC, Riano-Umbarila L, Rudino-Pinera E, Becerril B, Possani LD, Torres-Larios A. Structural basis of neutralization of the major toxic component from the scorpion Centruroides noxius Hoffmann by a human-derived single-chain antibody fragment. J Biol Chem 286: 20892-20900, 2011.
30. Case DA, Cheatham TE, III, Darden T, Gohlke H, Luo R, Merz KM, Onufriev A, Simmerling C, Wang B, Woods R. The Amber biomolecular simulation programs. J Comput Chem 26: 1668-1688, 2005.
31. Case DA, Darden TA, Cheatham TE, III, Simmerling CL, Wang J, Duke RE, Luo R, Walker RC, Zhang W, Merz KM, Roberts B, Hayik S, Roitberg S, Seabra G, Swails J, Goetz AW, Kolossvary I, Wong KF, Paesani F, Vanicek J, Wolf RM, Liu J, Wu X, Brozell SR, Steinbrecher T, Gohlke H, Cai Q, Ye X, Wang J, Hsieh MJ, Cui G, Roe DR, Mathews DH, Seetin MG, Salomon-Ferrer R, Sagui C, Babin V, Luchko T, Gusarov S, Kovalenko A, Kollman PA. AMBER 12. San Francisco: Univ. of California, 2012.
32. Catterall WA, Cestele S, Yarov-Yarovoy V, Yu FH, Konoki K, Scheuer T. Voltagegated ion channels and gating modifier toxins. Toxicon 49: 124-141, 2007.
33. Catterall WA, Goldin AL, Waxman SG. International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol Rev 57: 397-409, 2005.
34. Cestéle S, Yarov-Yarovoy V, Qu Y, Sampieri F, Scheuer T, Catterall WA. Structure and function of the voltage sensor of sodium channels probed by a β-scorpion toxin. J Biol Chem 281: 21332-21344, 2006.
35. Chakrapani S, Cuello LG, Cortes DM, Perozo E. Structural dynamics of an isolated voltage-sensor domain in a lipid bilayer. Structure 16: 398-409, 2008.
36. Chen R, Li L, Weng Z. ZDOCK: an initial-stage protein-docking algorithm. Proteins: Struct Funct Genet 52: 80-87, 2003.
37. Chen R, Weng Z. A novel shape complementarity scoring function for protein-protein docking. Proteins: Struct Funct Genet 51: 39700408, 2003.
38. Chen J, Im W, Brooks CL III. Balancing solvation and intramolecular interactions: toward a consistent generalized Born force field. J Am Chem Soc 128: 3728-3736, 2009.
39. Chen PC, Kuyucak S. Mechanism and energetics of charybdotoxin unbinding from a potassium channel from molecular dynamics simulations. Biophys J 96: 2577-2588, 2009.
40. Chen X, Wang Q, Ni F, Ma J. Structure of the full-length Shaker potassium channel Kv1.2 by normal-mode-based X-ray crystallographic refinement. Proc Natl Acad Sci USA 107: 11352-11357, 2010.
41. Chen PC, Kuyucak S. Accurate determination of the binding free energy for KcsAcharybdotoxin complex from the potential of mean force calculations with restraints. Biophys J 100: 2466-2474, 2011.
42. Chen R, Robinson A, Gordon D, Chung SH. Modeling the binding of three toxins to the voltage-gated potassium channel (Kv1.3). Biophys J 101: 2652-2660, 2011.
43. Chen PC, Kuyucak S. Developing a comparative docking protocol for the prediction of peptide selectivity profiles: investigation of potassium channel toxins. Toxins 4: 110-138, 2012.
44. Chen R, Chung SH. Binding modes of μ-conotoxin to the bacterial sodium channel (NaVAb). Biophys J 102: 483-488, 2012.
45. Chen R, Chung SH. Engineering a potent and specific blocker of voltage-gated potassium channel Kv1.3, a target for autoimmune diseases. Biochemistry 51: 1976-1982, 2012.
46. Chen R, Chung SH. Structural basis of the selective block of Kv1.2 by maurotoxin from computer simulations. PLoS One 7: e47253, 2012.
47. Chen R, Chung SH. Conserved functional surface of anti-mammalian scorpion β-toxins. J Phys Chem B 116: 4796-4800, 2012.
48. Chen R, Chung SH. Binding modes and functional surface of anti-mammalian scorpion α-toxins to sodium channels. Biochemistry 51: 7775-7782, 2012.
49. Chouidhary G, Aliste MP, Tieleman DP, French RJ, Dudley SC Jr. Docking of muconotoxin GIIIA in the sodium channel outer vestibule. Channels 1: 344-352, 2007.
50. Chung SH, Allen TW, Kuyucak S. Conducting-state properties of the KcsA potassium channel from molecular and Brownian dynamics simulations. Biophys J 82: 628-645, 2002.
51. Chung SH, Corry B. Conduction properties of KcsA measured using Brownian dynamics with flexible carbonyl groups in the selectivity filter. Biophys J 93: 44-53, 2007.
52. Clark RJ, Akcan M, Kaas Q, Daly NL, Craik DJ. Cyclization of conotoxins to improve their biopharmaceutical properties. Toxicon 59: 446-455, 2012.
53. Claussen H, Buning C, Rarey M, Lengauer T. FlexE: efficient molecular docking considering protein structure variations. J Mol Biol 308: 377-395, 2001.
54. Cornell W, Cieplak P, Bayly C, Gould I, Merz K, Ferguson D, Spellmeyer D, Fox T, Caldwell J, Kollman P. A second generation force field for the simulation of proteins, nucleic acids, and organic molecules. J Am Chem Soc 117: 5179-5197, 1995.
55. Corry B, Allen TW, Kuyucak S, Chung SH. A model of calcium channels. Biochim Biophys Acta 1509: 1-6, 2000.
56. Corry B, Allen TW, Kuyucak S, Chung SH. Electrostatic basis of valence selectivity in cationic channels. Biophys J 80: 195-214, 2001.
57. Corry B, Vora T, Chung SH. Mechanisms of permeation and selectivity in calcium channels. Biochim Biophys Acta 1711: 72-86, 2005.
58. Cui M, Shen J, Briggs JM, Fu W, Wu J, Zhang Y, Luo X, Chi Z, Ji R, Jiang H, Chen K. Brownian dynamics simulations of the recognition of the scorpion toxin P05 with the small-conductance calcium-activated potassium channels. J Mol Biol 318: 417-428, 2002.
59. Cui M, Shen J, Briggs JM, Luo X, Tan X, Jiang H, Chen K. Brownian dynamics simulations of interaction between scorpion toxin Lq2 and potassium ion channel. Biophys J 80: 1659-1669, 2001.
60. Darden T, York D, Pedersen L. Particle mesh Ewald: An N-log(N) method for Ewald sums in large systems. J Chem Phys 98: 10089-10092, 1993.
61. Darve E, Pohorille A. Calculating free energies using average force. J Chem Phys 115: 9169-9183, 2001.
62. De Vries SJ, van Dijk ADJ, Krzeminski M, van Dijk M, Thureau A, Hsu V, Wassenaar T, Bonvin AMJJ. HADDOCK versus HADDOCK: new features and performance of HADDOCK2.0 on the CAPRI targets. Proteins 69: 726-733, 2007.
63. Dekan Z, Vetter I, Daly NL, Craik DJ, Lewis RJ, Alewood PF. α-Conotoxin imi incorporating stable cystathionine bridges maintains full potency and identical threedimensional structure. J Am Chem Soc 133: 15866-15869, 2011.
64. DeSimone CV, Lu Y, Bondarenko VE, Morales MJ. S3b amino acid substitutions and ancillary subunits alter the affinity of Heteropoda venatoria toxin 2 for Kv4.3. Mol Pharmacol 76: 125-133, 2009.
65. DeSimone CV, Zarayskiy VV, Bondarenko VE, Morales MJ. Heteropoda toxin 2 interaction with Kv4.3, Kv4.1 reveals differences in gating modification. Mol Pharmacol 80: 345-355, 2011.
66. Dey R, Chen L. In search of allosteric modulators of a7-nAChR by solvent density guided virtual screening. J Biomol Struct Dyn 28: 695-715, 2011.
67. Dib-Hajj S, Priestly T. Voltage-gated sodium channels. In: Ion Channels: From Structure to Function, edited by Kew J, Davies C. Oxford, UK: Oxford Univ. Press, 2010.
68. Dib-Hajj SD, Cummins TR, Black JA, Waxman SG. Sodium channels in normal and pathological pain. Annu Rev Neurosci 33: 325-347, 2010.
69. Diochot S, Drici MD, Moinier D, Fink M, Lazdunski M. Effects of phrixotoxins on the Kv4 family of potassium channels and implications for the role of Ito1 in cardiac electrogenesis. Br J Pharmacol 126: 251-263, 1999.
70. Dominguez C, Bolens R, Bonvin AMJJ. HADDOCK: a protein-protein docking approach based on biochemical or biophysical information. J Am Chem Soc 125: 1731-1737, 2003.
71. + conduction and selectivity. Science 280: 69-77, 1998.
72. Duch DS, Recio-Pinto E, Frenkel C, Urban BW. Human brain sodium channels in bilayers. Brain Res 464: 171-177, 1988.
73. Dunlop J, Bowlby M, Peri R, Vasilyev D, Arias R. High-throughput electro-physiology: an emerging paradigm for ion-channel screening and physiology. Nature Rev Drug Discovery 7: 358-368, 2008.
74. Edwards S, Corry B, Kuyucak S, Chung SH. Continuum electrostatics fails to describe ion permeation in the gramicidin channel. Biophys J 83: 1348-1360, 2002.
75. Eldridge MD, Murray CW, Auton TR, Paolini GV, Mee RP. Empirical scoring functions. I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes. J Comp Aided Mol Des 11: 425-445, 1997.
76. + channel: a computational approach based on experimental distance restraints extracted from thermodynamic mutant cycles. Biophys J 83: 2595-2609, 2002.
77. Ermak DL, McCammon AJ. Brownian dynamics with hydrodynamic interactions. J Chem Phys 69: 1352-1360, 1978.
78. Fainzilber M, Kofman O, Zlotkin E, Gordon D. A new neurotoxin receptor site on sodium channels is identified by a conotoxin that affects sodium channel inactivation in mollusks and acts as an antagonist in rat brain. J Biol Chem 269: 2574-2580, 1994.
79. Fajloun Z, Mosbah A, Carlier E, Mansuelle P, Sandoz G, Fathallah M, di Luccio E, Devaux C, Rochat H, Darbon H, De Waard M, Sabatier JM. Maurotoxin versus Pi1/ HsTx1 scorpion toxins. Toward new insights in the understanding of their distinct disulfide bridge patterns. J Biol Chem 275: 39394-39402, 2000.
80. Farid R, Day T, Friesner RA, Pearlstein RA. New insights about HERG blockade obtained from protein modeling, potential energy mapping, and docking studies. Bioorg Med Chem 14: 3160-3173, 2006.
81. Feig M, Brooks CL 3rd. Recent advances in the development and application of implicit solvent models in biomolecule simulations. Curr Opin Struct Biol 14: 217-224, 2004.
82. Ferrari AM, Wei BQ, Costantino L, Shoichet BK. Soft docking and multiple receptor conformations in virtual screening. J Med Chem 47: 5076-5084, 2004.
83. Frenkel C, Wartenberg HC, Duch DS, Urban BW. Steady-state properties of sodium channels from healthy and tumorous human brain. Brain Res 59: 22-34, 1998.
84. Fu W, Cui M, Briggs JM, Huang X, Xiong B, Zhang Y, Luo X, Shen J, Ji R, Jiang H, Chen K. Brownian dynamics simulations of the recognition of the scorpion toxin maurotoxin with the voltage-gated potassium ion channels. Biophys J 83: 2370-2385, 2002.
85. Gaiday A, Levandovskiy I, Byler K, Shubina T. Mechanism of influenza a m2 ionchannel inhibition: a docking and qsar study. Computat Sci 360-368, 2008.
86. Gallicchio E, Levy R. AGBNP: an analytic implicit solvent model suitable for molecular dynamics simulations and high-resolution modeling. J Comput Chem 25: 479-499, 2004.
87. Gallicchio E, Zhang LY, Levy RM. The SGB/NP hydration free energy model based on the surface generalized born solvent reaction field and novel nonpolar hydration free energy estimators. J Comput Chem 23: 517-529, 2002.
88. Gilson MK, Zhou HX. Calculation of protein-ligand binding affinities. Annu Rev Biophys Biomol Struct 36: 21-42, 2007.
89. Giorgetti A, Carloni P. Molecular modeling of ion channels: structural predictions. Curr Opin Chem Biol 7: 150-156, 2003.
90. Gohlke H, Hendlich M, Klebe G. Knowledge-based scoring function to predict protein-ligand interactions. J Mol Biol 295: 337-356, 2000.
91. Gohlke H, Klebe G. Statistical potentials and scoring functions applied to proteinligand binding. Curr Opin Struct Biol 11: 231-235, 2001.
92. Gordon D, Krishnamurthy V, Chung SH. Generalized Langevin models of molecular dynamics simulations, with applications to ion channels. J Chem Phys 131: 134102-1-134102-11, 2009.
93. Gordon D, Chen R, Ho J, Coote ML, Chung SH. Rigid body Brownian dynamics as a tool for studying ion channel blockers. J Phys Chem B 116: 1933-1941, 2012.
94. Gordon D, Chung SH. Permeation and block of the Kv1.2 channel examined using Brownian and molecular dynamics. Biophys J 101: 2671-2678, 2011.
95. Gordon D, Hoyles M, Chung SH. Algorithm for rigid-body Brownian dynamics. Phys Rev E 80: 066703-1-066703-12, 2009.
96. Gordon D, Karbat I, Ilan N, Cohen L, Kahn R, Gilles N, Dong K, Stühmer W, Tytgat J, Gurevitz M. The differential preference of scorpion α-toxins for insect or mammalian sodium channels: implications for improved insect control. Toxicon 49: 452-472, 2007.
97. Gordon D, Chen R, Ho J, Coote ML, Chung SH. Rigid body brownian dynamics as a tool for studying ion channel blockers. J Phys Chem B 116: 1933-1941, 2012.
98. Gordon D, Krishnamurthy V, Chung SH. A generalised Langevin algorithm for studying permeation across biological ion channels. Mol Phys 108: 1353-1361, 2008.
99. Gray JJ. High-resolution protein-protein docking. Curr Opin Struct Biol 16: 183-193, 2006.
100. + channels, types Kv1.1, 12, 13, 15, and 31, stably expressed in mammalian cell lines. Mol Pharmacol 45: 1227-1234, 1994.
101. Grubmuller H. Predicting slow structural transitions in macromolecular systems: conformational flooding. Phys Rev E 52: 2893-2906, 1995.
102. Guidoni L, Carloni P. Tetraethylammonium binding to the outer mouth of the KcsA potassium channel: implications for ion permeation. J Recept Signal Transduct Res 22: 315-331, 2002.
103. Gurevitz M, Karbat I, Cohen L, Ilan N, Kahn R, Turkov M, Stankiewicz M, Stühmer W, Dong K, Gordon D. The insecticidal potential of scorpion β-toxins. Toxicon 49: 473-489, 2007.
104. Gutman GA, Chandy KG, Grissmer S, Lazdunski M, McKinnon D, Pardo LA, Robertson GA, Rudy B, Sanguinetti MC, Stuhmer W, Wang X. International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels. Pharmacol Rev 57: 473-508, 2005.
105. Hansen HS, Hünenberger PH. Using the local elevation method to construct optimized umbrella sampling potentials: calculation of the relative free energies and interconversion barriers of glucopyranose ring conformers in water. J Comput Chem 31: 1-23, 2010.
106. Hess B, Kutzner C, vand der Spoel D, Lindahl E. GROMACS 4: algorithms for highly efficient, load-balanced molecular simulation. J Chem Theory Comput 4: 435-447, 2008.
107. Housset D, Habersetzer-Rochat C, Astier JP, Fontecilla-Camps JC. Crystal structure of toxin II from the scorpion Androctonus australis Hector refined at 1.3 A resolution. J Mol Biol 238: 88-103, 1994.
108. Hoyles M, Krishnamurthy V, Sisik M, Chung SH. Brownian dynamics theory for predicting internal and external blockages of tetraethylammonium (TEA) in the KcsA potassium channel. Biophys J 94: 366-378, 2008.
109. Huang PT, Shiau YS, Lou KL. The interaction of spider gating modifier peptides with voltage-gated potassium channels. Toxicon 49: 285-292, 2007.
110. Huang SY, Zou X. Ensemble docking of multiple protein structures: considering protein structural variations in molecular docking. Proteins 66: 399-421, 2007.
111. Huang Z, Wong CF. Docking flexible peptide to flexible protein by molecular dynamics using two implicit solvent models: an evaluation in protein kinase and phosphatase systems. J Phys Chem B 113: 14343-14354, 2007.
112. Huber T, Torda AE, van Gunsteren WF. Local elevation: a method for improving the searching properties of molecular dynamics simulation. J Comput Aided Mol Des 8: 695-708, 1994.
113. Huey R, Morris GM, Olson AJ, Goodsell DS. J Comput Chem 28: 1145-1152, 2007.
114. Iannuzzi M, Laio A, Parrinello M. Efficient exploration of reactive potential energy surfaces using Car-Parrinello molecular dynamics. Phys Rev Lett 90: 238302, 2003.
115. Im W, Lee S, Brooks CL III. Generalized Born model with a simple smoothing function. J Comput Chem 24: 1691-1702, 2003.
116. + channels. Proc Natl Acad Sci USA 107: 5833-5838, 2010.
117. Jiang Y, Lee A, Chen J, Cadene M, Chait B, Mackinnon R. Crystal structure and mechanism of a calcium-gated potassium channel. Nature 417: 515-522, 2002.
118. + channel. Nature 423: 33-41, 2003.
119. Jin L, Wu Y. Molecular mechanism of the sea anemone toxin ShK recognizing the Kv1.3 channel explored by docking and molecular dynamic simulations. J Chem Inf Model 47: 1967-1972, 2007.
120. 3C, 15Ntriple-resonance nuclear magnetic resonance spectroscopy. Biochemistry 33: 15061-15070, 1994.
121. Jung HJ, Lee JY, Kim SH, Eu YJ, Shin SY, Milescu M, Swartz KJ, Kim JI. Solution structure and lipid membrane partitioning of VSTx1, an inhibitor of the KvAP potassium channel. Biochemistry 44: 6015-6023, 2005.
122. Kahn R, Karbat I, Ilan N, Cohen L, Sokolov S, Catterall WA, Gordon D, Gurevitz M. Molecular requirements for recognition of brain voltage-gated sodium channels by scorpion α-toxins. J Biol Chem 284: 20684-20691, 2009.
123. Kalman K, Pennington MW, Lanigan MD, Nguyen A, Rauer H, Mahnir V, Paschetto K, Kem WR, Grissmer S, Gutman GA, Christian EP, Cahalan MD, Norton RS, Chandy KG. ShKDap22 a potent Kv1.3-specific immunosuppressive polypeptide. J Biol Chem 273: 32697-32707, 1998.
124. Khabiri M, Nikouee A, Cwiklik L, Grissmer S, Ettrich R. Charybdotoxin unbinding from the mKv1.3 potassium channel: a combined computational and experimental study. J Phys Chem B 115: 11490-11500, 2011.
125. Khoo KK, Wilson MJ, Smith BJ, Zhang MM, Gulyas J, Yoshikami D, Rivier JE, Bulaj G, Norton RS. Lactam-stabilized helical analogues of the analgesic μ-conotoxin kiiia. J Med Chem 54: 7558-7566, 2011.
126. Koishi R, Xu H, Ren D, Navarro B, Spiller BW, Shi Q, Clapham DE. A superfamily of voltage-gated sodium channels in bacteria. J Biol Chem 279: 9532-9538, 2004.
127. Kollman PA. Free energy calculations: applications to chemical and biochemical phenomena. Chem Rev 93: 2395-2417, 1993.
128. Kollman PA, Massova I, Reyes C, Kuhn B, Huo S, Chong L, Lee M, Lee T, Duan Y, Wang W, Donini O, Cieplak P, Srinivasan J, Case DA, Cheatham TE. Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc Chem Res 33: 889-897, 2000.
129. Koppensteiner WA, Sippl MJ. Knowledge-based potentials-back to the roots. Biochemistry 63: 247-252, 1998.
130. Krezel AM, Kasibhatla C, Hidalgo P, MacKinnon R, Wagner G. Solution structure of the potassium channel inhibitor agitoxin 2: caliper for probing channel geometry. Protein Sci 4: 1478-1489, 1995.
131. Krueger BA, Weil T, Schneider G. Comparative virtual screening and novelty detection for NMDA-GlycineB antagonists. J Comput Aided Mol Des 23: 869-881, 2009.
132. Kumar S, Bouzida D, Swendsen RH, Kollman PA, Rosenberg JM. The weighted histogram analysis method for free-energy calculations on biomolecules. I. The method. J Comput Chem 13: 1011-1021, 1992.
133. Kuntz ID, Blaney JM, Oatley SJ, Langridge R, Ferrin TE. A geometric approach to macromolecule-ligand interactions. J Mol Biol 161: 269-288, 1982.
134. Kutluay E, Roux B, Heginbotham L. Rapid intracellular TEA block of the KcsA potassium channel. Biophys J 88: 1018-1029, 2005.
135. Kuyucak S, Andersen OS, Chung SH. Models of permeation in ion channels. Rep Prog Phys 64: 1427-1472, 2001.
136. Lang PT, Brozell SR, Mukherjee S, Pettersen EF, Meng EC, Thomas V, Rizzo RC, Case DA, James TL, Kuntz ID. DOCK 6: combining techniques to model RNA-small molecule complexes. RNA 15: 1219-1230, 2009.
137. Lange A, Giller K, Hornig S, Martin-Eauclaire MF, Pongs O, Becker S, Baldus M. Toxin-induced conformational changes in a potassium channel revealed by solid-state NMR. Nature 440: 959-962, 2006.
138. Lanigan MD, Kalman K, Lefievre Y, Pennington M, Chandy KG, Norton RS. Mutating a critical lysine in ShK toxin alters its binding configuration in the pore-vestibule region of the voltage-gated potassium channel, Kv1.3. Biochemistry 41: 11963-11971, 2002.
139. Lee MS, Feig M, Salsbury, FR Jr, Brooks CL III. New analytic approximation to the standard molecular volume definition and its application to generalized Born calculations. J Comput Chem 24: 1348-1356, 2003.
140. Lee CW, Kim S, Roh SH, Endoh H, Kodera Y, Maeda T, Kohno T, Wang JM, Swartz KJ, Kim JI. Solution structure and functional characterization of SGTx1, a modifier of Kv2.1 channel gating. Biochemistry 43: 890-897, 2004.
141. Lee SY, MacKinnon R. A membrane-access mechanism of ion channel inhibition by voltage sensor toxins from spider venom. Nature 430: 232-235, 2004.
142. Leipold E, Hansel A, Olivera BM, Terlau H, Heinemann SH. Molecular interaction of-conotoxins with voltage-gated sodium channels. FEBS Lett 3881-3884, 2005.
143. Levy RM, Zhang LY, Gallicchio E, Felts AK. On the nonpolar hydration free energy of proteins: surface area and continuum solvent models for the solute-solvent interaction energy. J Am Chem Soc 125: 9523-9530, 2003.
144. Li X, Keskin O, Ma B, Nussinov R, Liang J. Protein-protein interactions: hot spots and structurally conserved residues often locate in complemented pockets that pre-organized in the unbound states: implications for docking. J Mol Biol 344: 781-795, 2004.
145. + channel. J Gen Physiol 115: 673-684, 2000.
146. Li-Smerin Y, Swartz KJ. Helical structure of the COOH terminus of S3 and its contribution to the gating modifier toxin receptor in voltage-gated ion channels. J Gen Physiol 117: 205-217, 2001.
147. + channel pore. Biochemistry 39: 8161-8170, 2000.
148. Lipkind GM, Fozzard HA. Molecular modeling of local anesthetic drug binding by voltage-gated sodium channels. Mol Pharmacol 68: 1611-1622, 2005.
149. Liu HL, Lin JC. Molecular docking of the scorpion toxin Tc1 to the structural model of the voltage-gated potassium channel Kv1.1 from human Homo sapiens. J Biomol Struct Dyn 21: 639-650, 2004.
150. Liu M, Wang S. MCDOCK: a Monte Carlo simulation approach to the molecular docking problem. J Comput Aided Mol Des 13: 435-451, 1999.
151. + channel. Science 309: 897-903, 2005.
152. + channel in a lipid membrane-like environment. Nature 450: 376-382, 2007.
153. +-channels. J Mol Recognit 16: 392-395, 2003.
154. +-channel drk1. J Mol Recognit 15: 175-179, 2002.
155. Luzhkov VB, Nilsson J, Arhem P, Åqvist J. Computational modelling of the open-state Kv 1.5 ion channel block by bupivacaine. Biochim Biophys Acta 1652: 35-51, 2003.
156. MacKerell, AD Jr, Bashford D, Bellott M, Dunbrack, RL Jr, Evanseck JD, Field MJ, Fischer S, Gao J, Guo H, Ha S, Joseph-McCarthy D, Kuchnir L, Kuczera K, Lau FTK, Mattos C, Michnick S, Ngo T, Nguyen DT, Prodhom B, Reiher WE, Roux B3rd, Schlenkrich M, Smith JC, Stote R, Straub J, Watanabe M, Wiorkiewicz-Kuczera J, Yin D, Karplus M. All-atom empirical potential for molecular modelling and dynamics studies of proteins. J Phys Chem B 102: 3586-3616, 1998.
157. MacKerell AD Jr, Feig M, Brooks CL III. Extending the treatment of backbone energetics in protein force fields: limitations of gas-phase quantum mechanics in reproducing protein conformational distributions in molecular dynamics simulations. J Comput Chem 25: 1400-1415, 2004.
158. Mandell JG, Roberts VA, Pique ME, Kotlovyi V, Mitchell JC, Nelson E, Tsigelny I, Ten Eyck LF. Protein docking using continuum electrostatics and geometric fit. Protein Eng 14: 105-113, 2001.
159. Marrink SJ, Risselada HJ, Yefimov S, Tieleman DP, de Vries AH. The martini force field: coarse grained model for biomolecular simulations. J Phys Chem B 111: 7812-7824, 2007.
160. Marvin L, De E, Cosette P, Gagnon J, Molle G, Lange C. Isolation, amino acid sequence and functional assays of SGTx1. The first toxin purified from the venom of the spider scodra griseipes. Eur J Biochem 265: 572-579, 1999.
161. Masetti M, Cavalli A, Recanatini M. Modeling the hERG potassium channel in a phospholipid bilayer: molecular dynamics and drug docking studies. J Comput Chem 29: 795-808, 2008.
162. McArthur JR, Singh G, O'Mara ML, McMaster D, Ostroumov V, Tieleman DP, French RJ. Orientation of μ-conotoxin PIIIA in a sodium channel vestibule, based on voltage dependence of its binding. Mol Pharmacol 80: 219-227, 2011.
163. Meng XY, Xu Y, Zhang HX, Mezei M, Cui M. Predicting protein interactions by Brownian dynamics simulations. J Biomed Biotech 2012: 121034/1-11, 2012.
164. Milescu M, Bosmans F, Lee S, Alabi AA, Kim JI, Swartz KJ. Interactions between lipids and voltage sensor paddles detected with tarantula toxins. Nat Struct Mol Biol 16: 1080-1085, 2009.
165. Milescu M, Vobecky J, Roh SH, Kim SH, Jung HJ, Kim JI, Swartz KJ. Tarantula toxins interact with voltage sensors within lipid membranes. J Gen Physiol 130: 497-511, 2007.
166. Miller AN, Long SB. Crystal structure of the human two-pore domain potassium channel K2P1. Science 335: 432-436, 2012.
167. Mintseris J, Pierce B, Wiehe K, Anderson R, Chen R, Weng Z. Integrating statistical pair potentials into protein complex prediction. Proteins Struct Funct Bioinfo 69: 511-520, 2007.
168. Mitchell J, Laskowski R, Alex A, Thornton J. BLEEPpotential of mean force describing protein-ligand interactions. I. Generating potential. J Comput Chem 20: 1165-1176, 1999.
169. Monticelli L, Kandasamy S, Periole X, Larson R, Tieleman D, Marrink S. The MARTINI coarse-grained force field: extension to proteins. J Chem Theory Comput 4: 819-834, 2008.
170. Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ. AutoDock4 and AutodockTools4: automated docking with selective receptor flexibility. J Comput Chem 30: 2785-2791, 2009.
171. Mouhat S, Teodorescu G, Homerick D, Visan V, Wulff H, Wu Y, Grissmer S, Darbon H, De Waard M, Sabatier JM. Pharmacological profiling of Orthochirus scrobiculosus toxin 1 analogs with a trimmed N-terminal domain. Mol Pharmacol 69: 354-362, 2006.
172. Moult J. Comparison of database potentials and molecular mechanics force fields. Curr Opin Struct Biol 7: 194-199, 1997.
173. Moy G, Corry B, Kuyucak S, Chung SH. Tests of continuum theories as models of ion channels. I. Poisson-Boltzmann theory versus Brownian dynamics. Biophys J 78: 2349-2363, 2000.
174. Muegge I, Martin Y. A general and fast scoring function for protein-ligand interactions: a simplified potential approach. J Med Chem 42: 791-804, 1999.
175. Mulolinax JW, Noid WG. Recovering physical potentials from a model protein databank. Proc Natl Acad Sci USA 107: 19867-19872, 2010.
176. Muster W, Breidenbach A, Fischer H, Kirchner S, Müller L, Pähler A. Computational toxicology in drug development. Drug Discovery Today 13: 303-310, 2008.
177. Narahashi T, Frazier DT. Site of action and active form of local anesthetics. Neurosci Res 4: 65-99, 1971.
178. Nilius B, Owsianik G, Voets T, Peters JA. Transient receptor potential cation channels in disease. Physiol Rev 87: 165-217, 2007.
179. + channel gate modifier hanatoxin and lipid bilayer membranes analyzed by molecular dynamics simulation. Eur Biophys J 35: 373-381, 2006.
180. Norton RS, Pallaghy PK. The cystine knot structure of ion channel toxins and related polypeptides. Toxicon 36: 1573-1583, 1998.
181. Obiol-Pardo C, Gomis-Tena J, Sanz F, Saiz J, Pastor M. A multiscale simulation system for the prediction of drug-induced cardiotoxicity. J Chem Inf Model 51: 483-492, 2011.
182. Omelyan IP. Algorithm for numerical integration of the rigid-body equations of motion. Phys Rev E 58: 1169-1172, 1998.
183. + channel using docking and molecular dynamics methods. FEBS Lett 579: 2939-2944, 2005.
184. Palma PN, Krippahl L, Wampler JE, Moura JJ. BiGGER: a new (soft) docking algorithm for predicting protein interactions. Proteins 39: 372-384, 2000.
185. + channel. Neuron 9: 307-313, 1992.
186. Patargias G, Zitzmann N, Dwek R, Fischer WB. Protein-protein interactions: modeling the hepatitis C virus ion channel p7. J Med Chem 49: 648-655, 2006.
187. Payandeh J, Scheuer T, Zheng N, Catterall WA. The crystal structure of a voltagegated sodium channel. Nature 475: 353-358, 2011.
188. Pennington MW, Byrnes ME, Zaydenberg I, Khaytin I, de Chastonay J, Krafte DS, Hill R, Mahnir VM, Volberg WA, Gorczyca W, Kem WR. Chemical synthesis and characterization of ShK toxin: a potent potassium channel inhibitor from a sea anemone. Int J Peptide Protein Res 46: 354-358, 1995.
189. Perry M, Sanguinetti M, Mitcheson J. Revealing the structural basis of action of herg potassium channel activators and blockers. J Physiol 588: 3157-3167, 2010.
190. Phillips JC, Braun R, Wang W, Gumbart J, Tajkhorshid E, Villa E, Chipot C, Skeel RD, Kale L, Schulten K. Scalable molecular dynamics with NAMD. J Comp Chem 26: 1781-1802, 2005.
191. Phillips LR, Milescu M, Li-Smerin YY, Mindell JA, Kim JI, Swartz KJ. Voltage-sensor activation with a tarantula toxin as cargo. Nature 436: 857-860, 2005.
192. Pietra F. Binding of ciguatera toxins to the voltage-gated Kv1.5 potassium channel in the open state Docking of gambierol and molecular dynamics simulations of a homology model. J Physical Organic Chem 21: 997-1001, 2008.
193. Pietra F. Docking and MD simulations of the interaction of the tarantula peptide psalmotoxin-1 with ASIC1a channels using a homology model. J Chem Inf Model 49: 972-977, 2009.
194. Pintar A, Possani LD, Delepierre M. Solution structure of toxin 2 from Centruroides noxius Hoffmann, a β-scorpion neurotoxin acting on sodium channels. J Mol Biol 287: 359-367, 1999.
195. +-channels. Eur J Biochem 264: 287-300, 1999.
196. Qadri YJ, Berdiev BK, Song Y, Lippton HL, Fuller CM, Benos DJ. Psalmotoxin-1 docking to human acid-sensing ion channel-1. J Biol Chem 284: 17625-17633, 2009.
197. Qadri YJ, Song Y, Fuller CM, Benos DJ. Amiloride docking to acid-sensing ion channel-1. J Biol Chem 285: 9627-9635, 2010.
198. Rajamani D, Thiel S, Vajda S, Camacho CJ. Anchor residues in protein-protein interactions. Proc Natl Acad Sci USA 101: 11287-11292, 2004.
199. + channel: application to ligand binding. Bioorganic Med Chem Lett 15: 1737-1741, 2005.
200. Rasid MD, Kuyucak S. Affinity and selectivity of ShK toxin for the Kv1 potassium channels from free energy simulations. J Phys Chem B 116: 4812-4822, 2012.
201. Recanatini M, Cavalli A, Masetti M. Modeling HERG and its interactions with drugs: recent advances in light of current potassium channel simulations. Chem Med Chem 3: 523-535, 2008.
202. Reiher IWH. Theoretical Studies of Hydrogen Bonding (PhD thesis). Cambridge, MA: Harvard, 1985.
203. Ren D, Navarro B, Xu H, Yue L, Shi Q, Clapham DE. A prokaryotic voltage-gated sodium channel. Science 294: 2372-2375, 2001.
204. Repasky MP, Shelley M, Friesner RA. Flexible ligand docking with glide. Curr Protocols Bioinfo 18: 8.12.1-8.12.36, 2002.
205. + channel. Nature 422: 180-185, 2003.
206. Saini L, Gupta SP, Kumar Satluri VSA. A QSAR study on some series of sodium and potassium channel blockers. Med Chem 5: 570-576, 2009.
207. Sanguinetti MC, Johnson JH, Hammerland LG, Kelbaugh PR, Volkmann RA, Saccomano NA, Mueller AL. Heteropodatoxins: peptides isolated from spider venom that block Kv4.2 potassium channels. Mol Pharmacol 51: 491-498, 1997.
208. Schiavon E, Sacco T, Cassulini RR, Gurrola G, Tempia F, Possani LD, Wanke E. Resurgent current and voltage sensor trapping enhanced activation by a β-scorpion toxin solely in Nav1.6 channel Significance in mice Purkinje neurons. J Biol Chem 281: 20326-20337, 2006.
209. Schmid N, Eichenberger AP, Choutko A, Riniker S, Winger M, Mark AE, van Gunsteren WF. Definition and testing of the GROMOS force-field versions 54A7 and 54B7. Eur Biophys J 40: 843-856, 2011.
210. Shieh CC, Coghlan M, Sullivan JP, Gopalakrishnan M. Potassium channels: molecular defects, diseases, and therapeutic opportunities. Pharmacol Rev 52: 557-594, 2000.
211. Silos-Santiago I. The role of tetrodotoxin-resistant sodium channels in pain states: are they the next target for analgesic drugs? Curr Opin Investig Drugs 9: 83-89, 2008.
212. Sippl MJ. Calculation of conformational ensembles from potentials of mean force. An approach to the knowledge-based prediction of local structures in globular proteins. J Mol Biol 213: 859-883, 1990.
213. Sonkusare S, Palade PT, Marsh JD, Telemaque S, Pesic A, Rusch N. Vascular calcium channels and high blood pressure: pathophysiology and therapeutic implications. Vasc Pharmacol 44: 131-142, 2006.
214. Spitzmüller A, Velec HFG, Klebe G. MiniMuDS: a new optimizer using knowledgebased potentials improves scoring of docking solutions. J Chem Inf Model 51: 1423-1430, 2011.
215. Srinivasan J, Cheatham T, III, Cieplak P, Kollman P, David A. Continuum solvent studies of the stability of DNA, RNA, and phosphoramidate-DNA helices. J Am Chem Soc 120: 9401-9409, 1998.
216. Staats PS, Yearwood T, Charapata SG, Presley RW, Wallace MS, Byas-Smith M, Fisher R, Bryce DA, Mangieri EA, Luther RR, Mayo M, McGuire D, Ellis D. Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial. JAMA 291: 63-71, 2004.
217. Stevens M, Peigneur S, Tytgat J. Neurotoxins and their binding areas on voltage-gated sodium channels. Front Pharmacol 2: 71, 2011.
218. Stevens M, Peigneur S, Dyubankova N, Lescrinier E, Herdewijn P, Tytgat J. Design of bioactive peptides from naturally occurring μ-conotoxin structures. J Biol Chem 2012.
219. Subandiradoss C, Sethumadhavan R. Molecular docking simulation of short-chain four disulphide bridged scorpion toxins with structural model of human voltage-gated potassium ion channel Kv1.3. The Open Struct Biol J 3: 75-83, 2009.
220. Swartz KJ. Tarantula toxins interacting with voltage sensors in potassium channels. Toxicon 49: 213-230, 2007.
221. Swartz KJ, MacKinnon R. An inhibitor of the Kv2.1 potassium channel isolated from the venom of a Chilean tarantula. Neuron 15: 941-949, 1995.
222. + channel through multiple binding sites. Neuron 18: 665-673, 1997.
223. + channels. Neuron 18: 675-682, 1997.
224. Swope W, Andersen H, Berens P, Wilson K. A computer simulation method for the calculation of equilibrium constants for the formation of physical clusters of molecules: application to small water clusters. J Chem Phys 76: 637, 1982.
225. + channels: common surface features of gating modifier toxins. J Mol Biol 297: 771-780, 2000.
226. + channel inhibition by combining 3D-QSAR pharmacophore and 2D-QSAR models. J Mol Model 18: 1023-1036, 2012.
227. Tanaka S, Scheraga HA. Medium-and long-range interaction parameters between amino acids for predicting three-dimensional structures of proteins. Macromolecules 9: 945-950, 1976.
228. + channel Kir2.2 at 31 Å resolution. Science 326: 1668-1674, 2009.
229. Terlau H, Olivera BM. Conus venoms: a rich source of novel ion channel-targeted peptides. Physiol Rev 84: 41-68, 2004.
230. Terlau H, Olivera BM. Conus venoms: a rich source of novel ion channel-targeted peptides. Physiol Rev 84: 41-68, 2004.
231. Thomas P, Dill K. Statistical potentials extracted from protein structures: how accurate are they? J Mol Biol 257: 457-469, 1996.
232. Tikhonov DB, Zhorov BS. Modeling P-loops domain of sodium channel: homology with potassium channels and interaction with ligands. Biophys J 88: 184-197, 2005.
233. Tran L, Choi SB, Al-Najjar BO, Yusuf M, Wahab HA, Le L. Discovery of potential M2 channel inhibitors based on the amantadine scaffold via virtual screening and pharmacophore modeling. Molecules 16: 10227-10255, 2011.
234. Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31: 455-461, 2010.
235. Tuckerman ME. Statistical Mechanics: Theory and Molecular Simulation. Oxford, UK: Oxford Univ. Press, 2010.
236. Tudor JE, Pallaghy PK, Pennington MW, Norton RS. Solution structure of ShK toxin, a novel potassium channel inhibitor from a sea anemone. Nat Struct Biol 3: 317-320, 1996.
237. Tugarinov V, Kustanovich I, Zilberberg N, Gurevitz M, Anglister J. Solution structures of a highly insecticidal recombinant scorpion α-toxin and a mutant with increased activity. Biochemistry 36: 2414-2424, 1997.
238. Vakser IA. Evaluation of GRAMM low-resolution docking methodology on the hemagglutinin-antibody complex. Proteins Suppl 1: 226-230, 1997.
239. Verdonk ML, Cole JC, Hartshorn MJ, Murray CW, Taylor RD. Improved proteinligand docking using GOLD. Proteins 52: 609-623, 2003.
240. Verkman AS, Galietta LJV. Chloride channels as drug targets. Nat Rev Drug Discov 8: 153-171, 2009.
241. Verlet L. Computer "experiments" on classical fluids. I. Thermodynamical properties of Lennard-Jones molecules. Phys Rev 159: 98-103, 1967.
242. Vora T, Corry B, Chung SH. A model of sodium channels. Biochim Biophys Acta 1668: 106-116, 2004.
243. Wang S, Morales MJ, Qu YJ, Bett GCL, Strauss HC, Rasmusson RL. Kv1.4 channel block by quinidine: evidence for a drug-induced allosteric effect. J Physiol 546: 387-401, 2003.
244. Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA. Development and testing of a general AMBER force field. J Comput Chem 25: 1157-1174, 2004.
245. Wang JM, Roh SH, Kim S, Lee CW, Kim JI, Swartz KJ. Molecular surface of tarantula toxins interacting with voltage sensors in Kv channels. Mol Pharmacol 69: 788-795, 2006.
246. Wang SY, Mitchell J, Tikhonov DB, Zhorov BS, Wang GK. How batrachotoxin modifies the sodium channel permeation pathway: computer modeling and site-directed mutagenesis. J Gen Physiol 123: 455-467, 2004.
247. + channel voltage sensor. Proc Natl Acad Sci USA 108: 15426-15431, 2011.
248. Wee CL, Bemporad D, Sands ZA, Gavaghan D, Sansom MSP. SGTx1, a Kv channel gatingmodifier toxin, binds to the interfacial region of lipid bilayers. Biophys J 92: L07-L09, 2007.
249. Wee CL, Gavaghan D, Sansom MSP. Interactions between a voltage sensor and a toxin via multiscale simulations. Biophys J 98: 1558-1565, 2010.
250. Wee CL, Ulmschneider MB, Sansom MSP. Membrane/toxin interaction energetics via serial multiscale molecular dynamics simulations. J Chem Theory Comput 6: 966-976, 2010.
251. Wee CL, Gavaghan D, Sansom MS. Lipid bilayer deformation and the free energy of interaction of a Kv channel gating-modifier toxin. Biophys J 95: 3816-3826, 2008.
252. Wei AD, Gutman GA, Aldrich R, Chandy KG, Grissmer S, Wulff H. International Union of Pharmacology. LII. Nomenclature and molecular relationships of calcium-activated potassium channels. Pharmacol Rev 57: 463-472, 2005.
253. Weis A, Katebzadeh K, Söderhjelm P, Nilsson I, Ryde U. Ligand affinities predicted with the MM/PBSA method: dependence on the simulation method and the force field. J Med Chem 49: 6596-6606, 2006.
254. West PJ, Bulaj G, Yoshikami D. Effects of-conotoxins PVIA and SVIE on sodium channels in the amphibian sympathetic nervous system. J Neurophysiol 94: 3916-3924, 2005.
255. + channel and gating regulation by G proteins, PIP2, and sodium. Cell 147: 199-208, 2011.
256. Woo HJ, Roux B. Calculation of absolute protein-ligand binding constants with the molecular dynamics free energy perturbation method. Methods Mol Biol 443: 109-120, 2008.
257. Wu Y, Cao Z, Yi H, Jiang D, Mao X, Liu H, Li W. Simulation of the interaction between ScyTx and small conductance calcium-activated potassium channel by docking and MM-PBSA. Biophys J 87: 105-112, 2004.
258. Wulff H, Castle NA, Pardo LA. Voltage-gated potassium channels as therapeutic targets. Nat Rev Drug Discov 8: 982-1001, 2009.
259. + channel, IKCa1: a potential immunosuppressant. Proc Natl Acad Sci USA 97: 8151-8156, 2000.
260. Yi H, Qiu S, Cao Z, Wu Y, Li W. Molecular basis of inhibitory peptide maurotoxin recognizing Kv1.2 channel explored by ZDOCK and molecular dynamic simulations. Proteins 70: 844-854, 2008.
261. Yi H, Qiu S, Wu Y, Li W, Wang B. Differential molecular information of maurotoxin peptide recognizing IKCa and Kv1.2 channels explored by computational simulation. BMC Struct Biol 11: 3, 2011.
262. Yu K, Fu W, Liu H, Luo X, Chen KX, Ding JP, Shen J, Jiang H. Computational simulations of interactions of scorpion toxins with the voltage-gated potassium ion channel. Biophys J 86: 3542-3555, 2004.
263. Yu L, Sun C, Song D, Shen J, Xu N, Gunasekera A, Hajduk PJ, Olejniczak ET. Nuclear magnetic resonance structural studies of a potassium channel-charybdotoxin complex. Biochemistry 44: 15834-15841, 2005.
264. + channels of the Kv4 family. Toxicon 45: 431-442, 2005.
265. Zhang JZ, Yarov-Yarovoy V, Scheuer T, Karbat I, Cohen L, Gordon D, Gurevitz M, Catterall WA. Structure-function map of the receptor site for β-scorpion toxins in domain II of voltage-gated sodium channels. J Biol Chem 286: 33641-33651, 2011.
266. Zhang R, Wang Z, Ling B, Liu Y, Liu C. Docking and molecular dynamics studies on the interaction of four imidazoline derivatives with potassium ion channel (kir6.2). Mol Simul 36: 166-174, 2010.